Poor management and accounting of military blood supplies could impact the Pentagon's ability to fight unless changes are made soon, according to a new report. If the United States engages in a major theater war over the next few years, the Defense Department's blood supply will be composed primarily of untested or expired red blood cells, the DOD inspector general contends. "DOD did not have accurate frozen red blood cell inventory reporting and accountability, which could impact major theater war...
